Compare
QT Imaging Holdings, Inc. vs Hyperfine, Inc. vs CapsoVision, Inc vs Escalon Medical Corp
| Latest fiscal year | QT Imaging Holdings, Inc. QTI | Hyperfine, Inc. HYPR | CapsoVision, Inc CV | Escalon Medical Corp ESMC |
|---|---|---|---|---|
| Year ended | 2025-12-31 | 2025-12-31 | 2025-12-31 | 2026-06-30 |
| Revenue | $18.93M | $13.56M | $13.55M | $12.74M |
| Revenue growth (YoY) | +287.9% | +5.2% | +15.3% | +5.7% |
| Gross margin | 45.4% | 49.8% | 52.9% | 43.7% (computed) |
| Operating margin | -23.4% | -273.4% | -188.3% | 0.4% |
| Net margin | -111.4% | -262.3% | -186.8% | 31.5% |
| Net income | -$21.08M | -$35.57M | -$25.32M | $4.01M |
| EPS (Diluted) | -$2.01 | -$0.43 | -$1.03 | $0.27 |
| Operating cash flow | -$8.96M | -$27.95M | -$22.86M | -$402.6K |
| Free cash flow | -$9.08M | -$29.13M | -$22.95M | -$407.0K |
| Cash & equivalents | $10.41M | $35.09M | n/a | $3.07M |
| Total assets | $23.02M | $55.26M | $18.16M | $9.13M |
| Total liabilities | $16.58M | $14.26M | $4.90M | $3.20M |
| Shareholders' equity | $6.45M | $41.01M | $13.26M | $5.93M |
| Return on year-end equity | -327.1% | -86.8% | -190.9% | 67.7% |
| Shares outstanding | 11.90M | n/a | 46.87M | 7.42M |
Revenue, most recent five fiscal years
| Fiscal year | QT Imaging Holdings, Inc. | Hyperfine, Inc. | CapsoVision, Inc | Escalon Medical Corp |
|---|---|---|---|---|
| Latest | $18.93M Ended 2025-12-31 | $13.56M Ended 2025-12-31 | $13.55M Ended 2025-12-31 | $12.74M Ended 2026-06-30 |
| 1 year earlier | $4.88M Ended 2024-12-31 | $12.89M Ended 2024-12-31 | $11.76M Ended 2024-12-31 | $12.05M Ended 2025-06-30 |
| 2 years earlier | $40.4K Ended 2023-12-31 | $11.03M Ended 2023-12-31 | n/a | $11.98M Ended 2024-06-30 |
| 3 years earlier | n/a | $6.81M Ended 2022-12-31 | n/a | $12.18M Ended 2023-06-30 |
| 4 years earlier | n/a | $1.50M Ended 2021-12-31 | n/a | $10.70M Ended 2022-06-30 |